Loading the section…

CAH: financial statements from SEC — TradeAlmanac

CAH

Cardinal Health, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	30/06/2025	30/06/2024
Revenue	222.58B	226.83B
Cost of revenue	214.41B	219.41B
Gross profit	8.17B	7.41B
Selling, general and administrative	5.38B	5.00B
Operating income	2.28B	1.24B
Interest expense	215M	51M
Pre-tax income	2.10B	1.20B
Income tax	532M	348M
Net income	1.56B	852M
Earnings per share	6.48	3.48
Earnings per share, diluted	6.45	3.45
Weighted average shares	241M	245M
Weighted average shares, diluted	242M	247M

Balance sheet

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	3.94B	2.78B	4.59B	3.87B	3.33B	3.81B	2.87B	5.13B
Receivables	13.65B	13.66B	13.77B

Cash flow

Metric	30/06/2025	30/06/2024
Operating cash flow	2.40B	3.76B
Depreciation and amortisation	790M	710M
Share-based compensation	244M	121M
Capital expenditure	547M	511M
Investing cash flow	−5.59B	−1.85B
Dividends paid	494M

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator